Neoleukin Therapeutics (NLTX) Institutional Ownership

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free NLTX Stock Alerts

$31.58

-2.06 (-6.12%)

(As of 04/18/2024 ET)

Compare

Current Institutional Ownership Percentage: 52.37%
Number of Institutional Buyers (last 12 months): 7
Total Institutional Inflows (last 12 months): $23.58M

Number of Institutional Sellers (last 12 months): 8
Total Institutional Outflows (last 12 months): $64.82M

Get NLTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neoleukin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NLTX Institutional Buying and Selling by Quarter

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

Neoleukin Therapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/18/2023	Vanguard Group Inc.	201,539	$796K	0.0%	-80.1%	2.144%
11/15/2023	Redmile Group LLC	582,443	$2.30M	0.1%	-80.0%	6.619%
11/15/2023	Kynam Capital Management LP	24,037	$95K	0.0%	-80.0%	0.273%
11/15/2023	Adage Capital Partners GP L.L.C.	310,000	$1.22M	0.0%	N/A	3.523%
10/23/2023	BML Capital Management LLC	98,664	$390K	0.4%	+315.4%	1.121%
8/15/2023	Western Standard LLC	860,882	$715K	0.6%	N/A	1.956%
Get the Latest News and Ratings for NLTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/11/2023	Renaissance Technologies LLC	937,223	$778K	0.0%	+2.5%	2.188%
8/11/2023	BlackRock Inc.	483,948	$402K	0.0%	-14.3%	1.130%
7/26/2023	Privium Fund Management B.V.	117,200	$95K	0.0%	N/A	0.274%
5/15/2023	Two Sigma Advisers LP	234,200	$164K	0.0%	-6.4%	0.547%
5/15/2023	Two Sigma Investments LP	226,694	$159K	0.0%	-24.2%	0.529%
5/15/2023	MYDA Advisors LLC	40,000	$28K	0.0%	N/A	0.093%
5/12/2023	Renaissance Technologies LLC	914,613	$640K	0.0%	-23.4%	2.136%
5/12/2023	BlackRock Inc.	564,475	$395K	0.0%	-8.1%	1.318%
5/12/2023	Bank of America Corp DE	1,156,845	$810K	0.0%	-28.8%	2.701%
5/9/2023	US Bancorp DE	44,346	$31K	0.0%	+111.2%	0.104%
2/15/2023	Moneta Group Investment Advisors LLC	12,375,246	$6.30M	0.0%	N/A	29.064%
2/15/2023	Jane Street Group LLC	60,667	$31K	0.0%	N/A	0.142%
2/15/2023	Millennium Management LLC	1,587,267	$808K	0.0%	-6.4%	3.728%
2/15/2023	Morgan Stanley	562,423	$286K	0.0%	-5.1%	1.321%
2/14/2023	Point72 Asset Management L.P.	136,675	$70K	0.0%	-93.4%	0.321%
2/14/2023	Two Sigma Investments LP	299,036	$152K	0.0%	-12.9%	0.702%
2/13/2023	Renaissance Technologies LLC	1,193,447	$607K	0.0%	-17.2%	2.803%
2/10/2023	Bank of America Corp DE	1,623,893	$827K	0.0%	+823.4%	3.814%
2/9/2023	HighTower Advisors LLC	48,409	$25K	0.0%	N/A	0.114%
11/15/2022	Two Sigma Investments LP	343,136	$220K	0.0%	+9.8%	0.806%
11/15/2022	Vanguard Group Inc.	1,025,886	$657K	0.0%	-8.7%	2.409%
11/14/2022	Point72 Asset Management L.P.	2,064,222	$1.32M	0.0%	+43.6%	4.848%
11/14/2022	Renaissance Technologies LLC	1,442,067	$923K	0.0%	-10.7%	3.387%
11/1/2022	Privium Fund Management UK Ltd	117,200	$75K	0.1%	N/A	0.275%
8/18/2022	Goldman Sachs Group Inc.	39,759	$41K	0.0%	-40.5%	0.093%
8/15/2022	State Street Corp	122,556	$126K	0.0%	-79.1%	0.288%
8/15/2022	Point72 Asset Management L.P.	1,437,417	$1.48M	0.0%	+17.3%	3.376%
8/15/2022	Opaleye Management Inc.	610,000	$628K	0.3%	-22.8%	1.433%
8/15/2022	Millennium Management LLC	2,116,143	$2.18M	0.0%	+71.2%	4.970%
8/13/2022	Virtu Financial LLC	35,649	$37K	0.0%	N/A	0.084%
8/13/2022	Renaissance Technologies LLC	1,614,260	$1.66M	0.0%	+27.2%	3.798%
8/12/2022	Northern Trust Corp	69,890	$72K	0.0%	-77.4%	0.164%
8/11/2022	JPMorgan Chase & Co.	85,512	$88K	0.0%	+210.0%	0.201%
8/9/2022	Pictet Asset Management SA	781,551	$805K	0.0%	-69.6%	1.839%
Tiny Biotech Stock Wins $75 Billion Patent (Ad) A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>>
8/8/2022	Simon Quick Advisors LLC	46,856	$49K	0.0%	N/A	0.110%
7/27/2022	Bailard Inc.	90,100	$93K	0.0%	N/A	0.212%
7/14/2022	Adviser Investments LLC	65,404	$67K	0.0%	+39.7%	0.154%
6/7/2022	Bank of America Corp DE	212,530	$399K	0.0%	+10.7%	0.500%
5/27/2022	Walleye Capital LLC	14,168	$27K	0.0%	N/A	0.033%
5/26/2022	Kestra Private Wealth Services LLC	24,000	$45K	0.0%	+100.0%	0.056%
5/17/2022	Walleye Capital LLC	14,168	$27K	0.0%	N/A	0.033%
5/17/2022	Shay Capital LLC	27,486	$52K	0.0%	N/A	0.065%
5/16/2022	Goldman Sachs Group Inc.	66,772	$126K	0.0%	+45.5%	0.157%
5/13/2022	Renaissance Technologies LLC	1,268,969	$2.39M	0.0%	+50.4%	2.986%
5/13/2022	Northern Trust Corp	308,838	$581K	0.0%	-5.4%	0.727%
5/13/2022	Candriam Luxembourg S.C.A.	781,577	$1.47M	0.0%	-8.9%	1.839%
5/13/2022	Vanguard Group Inc.	1,280,501	$2.41M	0.0%	-20.0%	3.013%
5/12/2022	Gyon Technologies Capital Management LP	36,803	$69K	0.0%	N/A	0.087%
5/12/2022	BlackRock Inc.	2,558,479	$4.81M	0.0%	-1.8%	6.021%
5/11/2022	ACT Capital Management LLC	199,000	$374K	0.4%	-6.4%	0.468%
5/11/2022	JPMorgan Chase & Co.	27,585	$52K	0.0%	-84.3%	0.065%
5/4/2022	Adviser Investments LLC	46,817	$88K	0.0%	+347.6%	0.110%
5/2/2022	Allspring Global Investments Holdings LLC	45,709	$85K	0.0%	N/A	0.108%
2/14/2022	PDT Partners LLC	39,462	$190K	0.0%	+90.0%	0.093%
2/14/2022	Redmile Group LLC	3,490,835	$16.83M	0.4%	-0.5%	8.228%
2/14/2022	Point72 Asset Management L.P.	1,010,790	$4.87M	0.0%	+1.1%	2.382%
2/14/2022	GSA Capital Partners LLP	130,899	$631K	0.1%	+73.6%	0.309%
2/11/2022	Renaissance Technologies LLC	843,612	$4.07M	0.0%	+11.5%	1.988%
2/10/2022	Pictet Asset Management SA	2,574,289	$12.41M	0.0%	-3.4%	6.067%
2/10/2022	Acadian Asset Management LLC	23,405	$112K	0.0%	N/A	0.055%
2/8/2022	Northern Trust Corp	326,497	$1.57M	0.0%	-7.1%	0.770%
2/3/2022	Los Angeles Capital Management LLC	51,453	$248K	0.0%	+20.7%	0.121%
2/3/2022	ACT Capital Management LLC	212,500	$1.02M	0.7%	-11.1%	0.501%
2/2/2022	New York State Common Retirement Fund	14,396	$69K	0.0%	-57.2%	0.034%
1/31/2022	Adviser Investments LLC	10,460	$50K	0.0%	N/A	0.025%
1/21/2022	Kestra Private Wealth Services LLC	12,000	$58K	0.0%	N/A	0.028%
1/21/2022	Pinnacle Wealth Planning Services Inc.	14,303	$69K	0.0%	N/A	0.034%
11/22/2021	EcoR1 Capital LLC	860,619	$6.22M	0.2%	-63.5%	2.028%
11/16/2021	Opaleye Management Inc.	1,047,300	$7.57M	1.4%	-9.4%	2.468%
11/16/2021	Two Sigma Advisers LP	174,600	$1.26M	0.0%	+192.5%	0.412%
11/16/2021	Two Sigma Investments LP	120,212	$869K	0.0%	+207.5%	0.283%
11/16/2021	Metropolitan Life Insurance Co NY	4,698	$34K	0.0%	-52.4%	0.011%
11/15/2021	Point72 Asset Management L.P.	1,000,000	$7.23M	0.0%	+13.2%	2.357%
11/15/2021	Marshall Wace LLP	19,421	$140K	0.0%	N/A	0.046%
11/15/2021	Granahan Investment Management Inc. MA	125,331	$906K	0.0%	-35.8%	0.295%
11/15/2021	GSA Capital Partners LLP	75,419	$545K	0.1%	N/A	0.178%
11/12/2021	Trexquant Investment LP	34,300	$248K	0.0%	+141.4%	0.081%
11/12/2021	Renaissance Technologies LLC	756,892	$5.47M	0.0%	+31.4%	1.784%
11/12/2021	Macquarie Group Ltd.	11,960	$86K	0.0%	+2,208.9%	0.028%
11/12/2021	The Manufacturers Life Insurance Company	11,580	$84K	0.0%	-45.8%	0.027%
11/12/2021	Geode Capital Management LLC	617,827	$4.47M	0.0%	+6.0%	1.456%
11/10/2021	Goldman Sachs Group Inc.	117,656	$850K	0.0%	-43.6%	0.277%
11/10/2021	Citigroup Inc.	6,773	$49K	0.0%	-88.6%	0.016%
11/9/2021	BlackRock Inc.	2,669,276	$19.30M	0.0%	+1.2%	6.291%
Tiny Biotech Stock Wins $75 Billion Patent (Ad) A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>>
11/9/2021	Candriam Luxembourg S.C.A.	858,173	$6.20M	0.0%	+67.6%	2.023%
11/8/2021	Los Angeles Capital Management LLC	42,633	$308K	0.0%	-8.0%	0.100%
11/2/2021	New York State Common Retirement Fund	33,672	$243K	0.0%	-27.9%	0.079%
11/1/2021	SG Americas Securities LLC	22,340	$162K	0.0%	N/A	0.053%
8/17/2021	Metropolitan Life Insurance Co NY	9,870	$91K	0.0%	+98,600.0%	0.023%
8/17/2021	Millennium Management LLC	157,971	$1.46M	0.0%	+7.9%	0.372%
8/17/2021	MetLife Investment Management LLC	14,552	$134K	0.0%	+281.3%	0.034%
8/17/2021	Price T Rowe Associates Inc. MD	35,534	$328K	0.0%	+16.1%	0.084%
8/16/2021	Bank of America Corp DE	184,214	$1.70M	0.0%	+481.9%	0.434%
8/16/2021	UBS Asset Management Americas Inc.	10,340	$95K	0.0%	N/A	0.024%

(Data available from 1/1/2016 forward)

NLTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NLTX shares?: During the previous two years, 38 institutional investors and hedge funds held shares of Neoleukin Therapeutics. The most heavily invested institutionals were Moneta Group Investment Advisors LLC ($6.30M), Redmile Group LLC ($2.30M), Candriam Luxembourg S.C.A. ($1.47M), Adage Capital Partners GP L.L.C. ($1.22M), Bank of America Corp DE ($810K), Millennium Management LLC ($808K), and Pictet Asset Management SA ($805K).Learn more on NLTX's institutional investors.
What percentage of Neoleukin Therapeutics stock is owned by institutional investors?: 52.37% of Neoleukin Therapeutics stock is owned by institutional investors. Learn more on NLTX's institutional investor holdings.
Which institutional investors have been buying Neoleukin Therapeutics stock?: Of the 26 institutional investors that purchased Neoleukin Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Moneta Group Investment Advisors LLC ($12.38M), Bank of America Corp DE ($1.47M), Millennium Management LLC ($880.44K), Western Standard LLC ($860.88K), Point72 Asset Management L.P. ($839.22K), Renaissance Technologies LLC ($793.26K), and Adage Capital Partners GP L.L.C. ($310K).

How much institutional buying is happening at Neoleukin Therapeutics?: Institutional investors have bought a total of 18,496,765 shares in the last 24 months. This purchase volume represents approximately $234.66M in transactions.
Which Neoleukin Therapeutics major shareholders have been selling company stock?: Of the 19 institutional investors that sold Neoleukin Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Redmile Group LLC ($2.33M), Point72 Asset Management L.P. ($1.93M), Pictet Asset Management SA ($1.79M), Vanguard Group Inc. ($1.23M), Renaissance Technologies LLC ($699.65K), Bank of America Corp DE ($467.05K), and State Street Corp ($463.07K).
How much institutional selling is happening at Neoleukin Therapeutics?: Institutional investors have sold a total of 10,150,081 shares in the last 24 months. This volume of shares sold represents approximately $171.29M in transactions.

Related Companies:

This page (NASDAQ:NLTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Neoleukin Therapeutics (NLTX) Institutional Ownership

NLTX Institutional Buying and Selling by Quarter

Neoleukin Therapeutics Major Shareholders & Ownership History

NLTX Institutional Ownership - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Neoleukin Therapeutics (NLTX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Neoleukin Therapeutics (NASDAQ:NLTX)

NLTX Institutional Buying and Selling by Quarter

Neoleukin Therapeutics Major Shareholders & Ownership History

NLTX Institutional Ownership - Frequently Asked Questions